Contemporary epidemiology of chronic liver disease and cirrhosis
Background & Aims Accurate estimates for the contemporary burden of chronic liver disease
(CLD) are vital for setting clinical, research, and policy priorities. We aimed to review the …
(CLD) are vital for setting clinical, research, and policy priorities. We aimed to review the …
[PDF][PDF] Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease
Nonalcoholic fatty liver disease (NAFLD) and resulting nonalcoholic steatohepatitis (NASH)
are highly prevalent in the United States, where they are a growing cause of cirrhosis and …
are highly prevalent in the United States, where they are a growing cause of cirrhosis and …
[HTML][HTML] Modeling nafld disease burden in china, france, germany, italy, japan, spain, united kingdom, and united states for the period 2016–2030
C Estes, QM Anstee, MT Arias-Loste, H Bantel… - Journal of …, 2018 - Elsevier
Background & Aims Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic
steatohepatitis (NASH) are increasingly a cause of cirrhosis and hepatocellular carcinoma …
steatohepatitis (NASH) are increasingly a cause of cirrhosis and hepatocellular carcinoma …
Mortality due to cirrhosis and liver cancer in the United States, 1999-2016: observational study
Objective To describe liver disease related mortality in the United States during 1999-2016
by age group, sex, race, cause of liver disease, and geographic region. Design …
by age group, sex, race, cause of liver disease, and geographic region. Design …
Carbon-dot-supported atomically dispersed gold as a mitochondrial oxidative stress amplifier for cancer treatment
Mitochondrial redox homeostasis, the balance between reactive oxygen species and
antioxidants such as glutathione, plays critical roles in many biological processes, including …
antioxidants such as glutathione, plays critical roles in many biological processes, including …
Tumor immune microenvironment and immunosuppressive therapy in hepatocellular carcinoma: a review
K Oura, A Morishita, J Tani, T Masaki - International journal of molecular …, 2021 - mdpi.com
Liver cancer has the fourth highest mortality rate of all cancers worldwide, with
hepatocellular carcinoma (HCC) being the most prevalent subtype. Despite great advances …
hepatocellular carcinoma (HCC) being the most prevalent subtype. Despite great advances …
Disease burden of hepatocellular carcinoma: a global perspective
M Sayiner, P Golabi, ZM Younossi - Digestive diseases and sciences, 2019 - Springer
Liver cancer is one of the leading causes of cancer-related mortality around the world.
Hepatocellular carcinoma (HCC) is the primary cancer of the liver, accounting for the …
Hepatocellular carcinoma (HCC) is the primary cancer of the liver, accounting for the …
Epidemiology of hepatocellular carcinoma: target population for surveillance and diagnosis
Hepatocellular carcinoma (HCC) is the sixth most common cancer and the second leading
cause of cancer mortality worldwide. Incidence rates of liver cancer vary widely between …
cause of cancer mortality worldwide. Incidence rates of liver cancer vary widely between …
[PDF][PDF] Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009
ZM Younossi, M Otgonsuren, L Henry… - …, 2015 - Wiley Online Library
Hepatocellular carcinoma (HCC) is increasingly reported in patients with nonalcoholic fatty
liver disease (NAFLD). Our aim was to assess the prevalence and mortality of patients with …
liver disease (NAFLD). Our aim was to assess the prevalence and mortality of patients with …
The changing epidemiology of liver diseases in the Asia–Pacific region
This Review presents current epidemiological trends of the most common liver diseases in
Asia–Pacific countries. Hepatitis B virus (HBV) remains the primary cause of cirrhosis; …
Asia–Pacific countries. Hepatitis B virus (HBV) remains the primary cause of cirrhosis; …